Low number of memory B cells in the salivary glands of patients with primary Sjögren's syndrome

References

• Jonsson R, Bolstad AI, Brokstad KA, Brun JG. Sjogren's syndrome—A plethora of clinical and immunological phenotypes with a complex genetic background. Ann. NY Acad. Sci.. 2007; 1108:433–447.
   PubMed Web of Science ®Google Scholar
• Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch. Intern. Med.. 2004; 164 12: 1275–1284.
   PubMedGoogle Scholar
• Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S. The complexity of Sjogren's syndrome: novel aspects on pathogenesis. Immunol. Lett.. 2011; 141 1: 1–9.
   PubMed Web of Science ®Google Scholar
• Mavragani CP, Tzioufas AG, Moutsopoulos HM. Sjogren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects. Int. Arch. Allergy Immunol.. 2000; 123 1: 46–57.
   PubMedGoogle Scholar
• Garberg H, Jonsson R, Brokstad KA. The serological pattern of autoantibodies to the Ro52, Ro60, and La48 autoantigens in primary Sjogren's syndrome patients and healthy controls. Scand. J. Rheumatol.. 2005; 34 1: 49–55.
   PubMed Web of Science ®Google Scholar
• Burbelo PD, Leahy HP, Issa AT, Groot S, Baraniuk JN, Nikolov NP, Illei GG, Iadarola MJ. Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome. Autoimmunity. 2009; 42 6: 515–524.
   PubMed Web of Science ®Google Scholar
• Franceschini F, Cavazzana I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity. 2005; 38 1: 55–63.
   PubMed Web of Science ®Google Scholar
• Gordon TP, Bolstad AL, Rischmueller M, Jonsson R, Waterman SA. Autoantibodies in primary Sjogren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity. 2001; 34 2: 123–132.
   PubMed Web of Science ®Google Scholar
• Hansen A, Lipsky PE, Dorner T. B cells in Sjogren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res. Ther.. 2007; 9 4: 218.
   PubMed Web of Science ®Google Scholar
• Bohnhorst JO, Thoen JE, Natvig JB, Thompson KM. Significantly depressed percentage of CD27+ (memory) B cells among peripheral blood B cells in patients with primary Sjogren's syndrome. Scand. J. Immunol.. 2001; 54 4: 421–427.
   PubMed Web of Science ®Google Scholar
• Bohnhorst JO, Bjorgan MB, Thoen JE, Jonsson R, Natvig JB, Thompson KM. Abnormal B cell differentiation in primary Sjogren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration. Clin. Immunol.. 2002; 103 1: 79–88.
   PubMed Web of Science ®Google Scholar
• Bohnhorst JO, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren's syndrome. J. Immunol.. 2001; 167 7: 3610–3618.
   PubMed Web of Science ®Google Scholar
• Hansen A, Gosemann M, Pruss A, Reiter K, Ruzickova S, Lipsky PE, Dorner T. Abnormalities in peripheral B cell memory of patients with primary Sjogren's syndrome. Arthritis Rheum.. 1897; 50 61908.
   Google Scholar
• Agematsu K, Hokibara S, Nagumo H, Komiyama A. CD27: A memory B-cell marker. Immunol. Today. 2000; 21 5: 204–206.
   PubMedGoogle Scholar
• Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med.. 1998; 188 9: 1679–1689.
   PubMed Web of Science ®Google Scholar
• Jung J, Choe J, Li L, Choi YS. Regulation of CD27 expression in the course of germinal center B cell differentiation: The pivotal role of IL-10. Eur. J. Immunol.. 2000; 30 8: 2437–2443.
   PubMed Web of Science ®Google Scholar
• Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, Lipsky PE, Radbruch A, Dorner T. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J. Immunol.. 2000; 165 10: 5970–5979.
   PubMed Web of Science ®Google Scholar
• Szyszko EA, Brokstad KA, Oijordsbakken G, Jonsson MV, Jonsson R, Skarstein K. Salivary glands of primary Sjogren's syndrome patients express factors vital for plasma cell survival. Arthritis Res. Ther.. 2011; 13 1: R2.
   PubMed Web of Science ®Google Scholar
• Szyszko EA, Brun JG, Skarstein K, Peck AB, Jonsson R, Brokstad KA. Phenotypic diversity of peripheral blood plasma cells in primary Sjogren's syndrome. Scand. J. Immunol.. 2011; 73 1: 18–28.
   PubMedGoogle Scholar
• Szyszko EA, Skarstein K, Jonsson R, Brokstad KA. Distinct phenotypes of plasma cells in spleen and bone marrow of autoimmune NOD.B10.H2b mice. Autoimmunity. 2011; 44 5: 415–426.
   PubMed Web of Science ®Google Scholar
• Klein U, Kuppers R, Rajewsky K. Human IgM+IgD+B cells, the major B cell subset in the peripheral blood, express V kappa genes with no or little somatic mutation throughout life. Eur. J. Immunol.. 1993; 23 12: 3272–3277.
   PubMed Web of Science ®Google Scholar
• Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med.. 1994; 180 1: 329–339.
   PubMed Web of Science ®Google Scholar
• Cambridge G, Leandro MJ, Teodorescu M, Manson J, Rahman A, Isenberg DA, Edwards JC. B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum.. 2006; 54 11: 3612–3622.
   PubMed Web of Science ®Google Scholar
• Vallerskog T, Gunnarsson I, Widhe M, Risselada A, Klareskog L, van Vollenhoven R, Malmstrom V, Trollmo C. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin. Immunol.. 2007; 122 1: 62–74.
   PubMed Web of Science ®Google Scholar
• Isaksen K, Jonsson R, Omdal R. Anti-CD20 treatment in primary Sjogren's syndrome. Scand. J. Immunol.. 2008; 68 6: 554–564.
   PubMed Web of Science ®Google Scholar
• Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, Vissink A, Kallenberg CG, Bootsma H. Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study. Arthritis Rheum.. 2005; 52 9: 2740–2750.
   PubMedGoogle Scholar
• Sacchi S, Federico M, Dastoli G, Fiorani C, Vinci G, Clo V, Casolari B. Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab. Crit. Rev. Oncol. Hematol.. 2001; 37 1: 13–25.
   PubMedGoogle Scholar
• Pijpe J, van Imhoff GW, Vissink A, van der Wal JE, Kluin PM, Spijkervet FK, Kallenberg CG, Bootsma H. Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma. Ann. Rheum. Dis.. 2005; 64 6: 958–960.
   PubMedGoogle Scholar
• Shih WJ, Ghesani N, Hongming Z, Alavi A, Schusper S, Mozley D. F-18 FDG positron emission tomography demonstrates resolution of non-Hodgkin's lymphoma of the parotid gland in a patient with Sjogren's syndrome: before and after anti-CD20 antibody rituximab therapy. Clin. Nucl. Med.. 2002; 27 2: 142–143.
   PubMedGoogle Scholar
• Kimby E. Tolerability and safety of rituximab (MabThera). Cancer Treat. Rev.. 2005; 31 6: 456–473.
   PubMed Web of Science ®Google Scholar
• Jonsson R, Kroneld U, Backman K, Magnusson B, Tarkowski A. Progression of sialadenitis in Sjogren's syndrome. Br. J. Rheumatol.. 1993; 32 7: 578–581.
   PubMedGoogle Scholar
• Jonsson R, Nginamau E, Szyszko E, Brokstad KA. Role of B cells in Sjogren's syndrome—From benign lymphoproliferation to overt malignancy. Front Biosci.. 2007; 12:2159–2170.
   PubMed Web of Science ®Google Scholar
• Jonsson MV, Skarstein K. Follicular dendritic cells confirm lymphoid organization in the minor salivary glands of primary Sjogren's syndrome. J. Oral Pathol. Med.. 2008; 37 9: 515–521.
   PubMedGoogle Scholar
• Vogelsang P, Brun JG, Oijordsbakken G, Skarstein K, Jonsson R, Appel S. Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjogren's syndrome. Ann. Rheum. Dis.. 2010; 69 6: 1235–1258.
   PubMed Web of Science ®Google Scholar
• Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, Wahren-Herlenius M, Jonsson R. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome. Arthritis Rheum.. 2003; 48 11: 3187–3201.
   PubMed Web of Science ®Google Scholar
• Tengner P, Halse AK, Haga HJ, Jonsson R, Wahren-Herlenius M. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjogren's syndrome. Arthritis Rheum.. 1998; 41 12: 2238–2248.
   PubMed Web of Science ®Google Scholar
• Barcellos KS, Nonogaki S, Enokihara MM, Teixeira MS, Andrade LE. Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjogren's syndrome. J. Rheumatol.. 2007; 34 6: 1283–1292.
   PubMedGoogle Scholar
• Halse AK, Wahren M, Jonsson R. Peripheral blood in Sjogren's syndrome does not contain increased levels of T lymphocytes reactive with the recombinant Ro/SS-A 52 kD and La/SS-B 48 kD autoantigens. Autoimmunity. 1996; 23 1: 25–34.
   PubMed Web of Science ®Google Scholar
• MacLennan IC. Germinal centers. Annu. Rev. Immunol.. 1994; 12:117–139.
   PubMed Web of Science ®Google Scholar
• Jonsson MV, Skarstein K, Jonsson R, Brun JG. Serological implications of germinal center-like structures in primary Sjogren's syndrome. J. Rheumatol.. 2007; 34 10: 2044–2049.
   PubMed Web of Science ®Google Scholar
• Hamel KM, Liarski VM, Clark MR. Germinal Center B-cells. Autoimmunity. 2012 (In press).
   Google Scholar
• Halse A, Harley JB, Kroneld U, Jonsson R. Ro/SS-A-reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjogren's syndrome. Clin. Exp. Immunol.. 1999; 115 1: 203–207.
   PubMed Web of Science ®Google Scholar
• Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, Burmester GR, Lipsky PE, Dorner T. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum.. 2002; 46 8: 2160–2171.
   PubMed Web of Science ®Google Scholar
• Dorner T, Hansen A, Jacobi A, Lipsky PE. Immunglobulin repertoire analysis provides new insights into the immunopathogenesis of Sjogren's syndrome. Autoimmun. Rev.. 2002; 1 3: 119–124.
   PubMedGoogle Scholar
• Aqrawi LA, Skarstein K, Bredholt G, Brun JG, Brokstad KA. Autoantigen-specific memory B cells in primary Sjogren's syndrome. Scand. J. Immunol.. 2012; 75 1: 61–68.
   PubMedGoogle Scholar
• Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis.. 2002; 61 6: 554–558.
   PubMed Web of Science ®Google Scholar
• Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann. Rheum. Dis.. 2005; 64 6: 913–920.
   PubMed Web of Science ®Google Scholar
• Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity. 2002; 16 1: 1–4.
   PubMed Web of Science ®Google Scholar